Status:
COMPLETED
A Simple Approach to Treat COVID-19 Patients at Home.
Lead Sponsor:
Mario Negri Institute for Pharmacological Research
Conditions:
COVID 19
Eligibility:
All Genders
18+ years
Brief Summary
The newly recognised disease COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which by early December 2019 had spread from China to the rest of the world, especi...
Eligibility Criteria
Inclusion
- Male and female adult (≥18 years old)
- Subjects with early mild symptoms of COVID-19, without waiting results of a nasopharyngeal swab, if any
- Informed consent
Exclusion
- Subjects who require immediate hospital admission because severe COVID-19 symptoms at onset according to family doctor opinion
Key Trial Info
Start Date :
February 8 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04794998
Start Date
February 8 2021
End Date
July 31 2021
Last Update
October 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Reserach Center for Rare Diseases "Aldo e Cele Daccò"
Ranica, BG, Italy, 24020